Studies, including those by Li et al. (96) have identified several novel lncRNAs as promising biomarkers and therapeutic targets for BPD, while Dong et al. (97) highlighted specific regulatory axes like miR17hg-miR-130b-3p-Robo2 and GM20455-miR-34a-5p-Brinp1. The gene discussed is ROBO2; the disease is bronchopulmonary dysplasia.